Clopidogrel-induced spontaneous pectoral hematoma

Area of Science:

• Cardiology
• Pharmacology
• Hematology

Background:

• Clopidogrel is a widely used oral antiplatelet agent for managing cardiovascular and cerebrovascular diseases.
• Common side effects include gastrointestinal disturbances; serious adverse events like intracranial hemorrhage and neutropenia are rare.
• Spontaneous pectoral hematoma is not a previously documented side effect of clopidogrel.

Observation:

• A case study involving an elderly woman receiving clopidogrel therapy.
• The patient developed a large spontaneous pectoral hematoma.

Findings:

• This case represents the first reported instance of spontaneous pectoral hematoma associated with clopidogrel use.
• The event occurred despite the absence of trauma, suggesting a direct link to the antiplatelet medication.

Implications:

• Highlights a potential, previously unrecognized risk associated with clopidogrel therapy.
• Suggests the need for increased vigilance and consideration of this rare complication in patients presenting with similar symptoms.
• May inform future clinical practice guidelines regarding clopidogrel monitoring and patient education.